Legal status by country
Is CJC-1295 with ipamorelin and GHRP-2 legal?
Written by Aaron CuhaReviewed Sep 2026
How CJC-1295 with ipamorelin and GHRP-2 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | Research use only; all three components are prohibited in sport at all times. | None recorded | None recorded | None recorded |
US FDA status: Not approved. None of the three components is an approved medicine in the United States and no regulator has evaluated any combination of them.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.